Skip to content

Debt Repayments at other companies

Lifevantage Corporation logo
Lifevantage CorporationLFVN
$0
NuSkin Enterprises logo
NuSkin EnterprisesNUS
$225M+45.2%
Kenvue logo
KenvueKVUE
$750M0.0%
Helen Of Troy logo
Helen Of TroyHELE
$4.69M+200%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$625K
Estee Lauder Companies Inc. logo
Estee Lauder Companies Inc.EL

Other financials

Income statement

See full
Revenue$64.9M-6.7%
Gross profit$44.4M-8.5%
Operating income-$1.8M+85.0%
Net income-$6.6M+34.3%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$204.4M-45.2%
Total debt$125.9M+756%
Total equity$55.2M+19.9%
Total assets$473.2M-29.8%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$224.0K+398%
Free cash flow-$5.8M-296%

Valuation

See full
Market cap$89.75M-61.5%
Enterprise value$11.24M-96.2%
P/S0.3×-0.4×

Profitability

See full
Gross margin64.9%+8.3pp
Operating margin-3.6%-1.6pp
Net margin-2%-0.9pp
FCF margin9.6%

Returns & leverage

See full
Return on equity-12%-5.4pp
Debt / equity2.3×+2.0×
Current ratio1.8×-5.7×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfConvertibleDebt.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beauty Health Company's debt repayments?
The Beauty Health Company (SKIN) reported debt repayments of $20.16M in Q1 2026.
What is the long-term trend for The Beauty Health Company's debt repayments?
Over 2 years (2021 to 2024), The Beauty Health Company's debt repayments has grown at a 458.7% compound annual growth rate (CAGR), from $5M to $156.08M.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.